Compare Lumentum (LITE) vs 10X Genomics Inc (TXG) Price & Performance

LumentumTrade

10X Genomics IncTrade

Price performance (Past 24H)

Key statistics

Lumentum vs 10X Genomics Inc — how do they compare? Lumentum trades at $1,104 (market cap $94.99B), while 10X Genomics Inc trades at $81 (market cap $10.07B). The key difference: Lumentum is far larger — about 9.4× 10X Genomics Inc's market cap, and 10X Genomics Inc is more actively traded (5,657,286 versus 4,855,776). Which is the better fit depends on your goals — on Pluang, investors hold Lumentum for 4 Days and 10X Genomics Inc for 91 Days on average.

	LITE	TXG
Market Cap	$94.99B	$10.07B
Volume	4,855,776	5,657,286
Sector	Technology	Health
52-Week High	$1.13K	$97.74
52-Week Low	$149.61	$11.48
Typical Hold Time	4 Days	91 Days
Enterprise Value	$93.92B	$9.59B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lumentum

No Aura AI signal available yet.

10X Genomics Inc

10x Genomics (TXG) trades at $82.37, up 8.24% over 24 hours, with a bearish technical signal and mixed analyst sentiment. The company reported a net loss of $43.54M in 2025, but revenue grew to $642.82M, and it has beaten EPS estimates for three consecutive quarters. Recent news highlights strong demand for its Atera platform and a patent victory, though profitability remains a challenge.

The outlook is cautiously optimistic, with growth potential from new product launches and spatial biology demand, but risks include persistent losses, high valuation multiples, and competitive pressures. The consensus price target is $74.30, below the current price, suggesting limited near-term upside.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LITE

54% Buy46% Sell

Avg holding period · 4 Days

TXG

97% Buy3% Sell

Avg holding period · 91 Days

Top news

Latest headlines on both assets

LITE

Lumentum hits strong demand amid AI data center growth, may be undervalued with $40 EPS target by 2028Seeking Alpha · 5 hours agoBullish Lumentum warns AI demand fills production capacity through early 2029, shares rise 4%.Proactive Investors · 9 hours agoBullish Optical stocks surge as capacity sold out through 2029, driven by strong AI data center demand.24/7 Wall Street · 11 hours agoBullish View details →

TXG

10x Genomics partners with Fred Hutch to advance cancer research using single cell and spatial technologies.PRNewsWire · 2 days agoBullish Five stocks drop sharply on Oct 6, led by ArriVent BioPharma after lung cancer drug trial failure.Danny Green · 2 days agoBearish View details →

About Lumentum

Lumentum develops photonic products, including optical components, transceivers, and lasers. Its technologies support data centers, communications networks, industrial manufacturing, and sensing applications.

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.